Cantitate/Preț
Produs

Molecular Targeting and Signal Transduction: Cancer Treatment and Research, cartea 119

Editat de Rakesh Kumar
en Limba Engleză Paperback – 24 apr 2013
Our limited understanding of cellular regulatory signal-transduction-networks has been a barrier to progress in improving the overall cure-rate of human cancers. Delineation of the physiologic roles of the specific regulatory signaling components, with known association with metastatic phenotypes, is a highly promising area which will likely provide the next generation of targeted strategies in the future of molecular cancer medicine. These signaling components are likely to be used in diagnosis, prognosis, and as novel targets for therapeutic development.
This book brings together up-to-date summaries by leading cancer researchers on the major principles of cancer cell biology: survival, apoptosis, adhesion, and cell cycle deregulation. It is directed at clinicians and scientists working in the areas of experimental and molecular therapeutics, molecular medicine, translational cancer research, and bio-medical sciences in general.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 106534 lei  6-8 săpt.
  Springer Us – 24 apr 2013 106534 lei  6-8 săpt.
Hardback (1) 107423 lei  6-8 săpt.
  Springer Us – 30 apr 2004 107423 lei  6-8 săpt.

Din seria Cancer Treatment and Research

Preț: 106534 lei

Preț vechi: 112141 lei
-5% Nou

Puncte Express: 1598

Preț estimativ în valută:
20388 21447$ 17012£

Carte tipărită la comandă

Livrare economică 09-23 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781475779684
ISBN-10: 1475779682
Pagini: 344
Ilustrații: VIII, 331 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.48 kg
Ediția:Softcover reprint of the original 1st ed. 2004
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Biology of the Epidermal Growth Factor Receptor Family.- Integrin Signaling in Cancer.- Regulators of Vascular Endothelial Growth Factor Expression in Cancer.- Integrin-Linked Kinase (ILK) in Combination Molecular Targeting.- P21-Activated Kinase 1: An Emerging Therapeutic Target.- Basis and Importance of SRC as a Target in Cancer.- Therapeutic Targeting of the Receptor Tyrosine Kinase Met.- Nuclear Factor-?B Activation Mediates Cellular Transformation, Proliferation, Invasion Angiogenesis and Metastasis of Cancer.- The P53 Pathway: Targets for the Development of Novel Cancer Therapeutics.- Runx Protein Signaling in Human Cancers.- Signal Transduction Mediated by Cyclin D1: from Mitogens to Cell Proliferation: A Molecular Target with Therapeutic Potential.- Signal Transduction Pathways in BCR-ABL Transformed Cells.- Estrogen Receptors and Anti-Estrogen Therapies.- Targeting Endothelin Axis in Cancer.- km23: A Novel TGF? Signaling Target Altered in Ovarian Cancer.

Caracteristici

Describes the key pathways and factors involved in this process. Distinguished leaders in the field discuss the therapeutic compounds and strategies being developed for the treatment of malignant disease